We are live on ! Find out more
EMB

Elefante Mark B Portfolio holdings

AUM $182M
1-Year Est. Return 17.71%
This Fund
S&P 500
This Quarter Est. Return
+6.45%
1 Year Est. Return
+17.71%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$156M
AUM Growth
+$23.2M
Cap. Flow
+$16.3M
Cap. Flow %
10.44%
Top 10 Hldgs %
45.39%
Holding
59
New
2
Increased
40
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$923K
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$835K
3
AMZN icon
Amazon
AMZN
+$752K
4
AAPL icon
Apple
AAPL
+$751K
5
AMAT icon
Applied Materials
AMAT
+$717K

Top Sells

Rank Stock Value
1
BALL icon
Ball Corp
BALL
+$525K
2
ADBE icon
Adobe
ADBE
+$316K
3
DE icon
Deere & Co
DE
+$203K
4
NVO
Novo Nordisk
NVO
+$97.5K
5
PEP icon
PepsiCo
PEP
+$76.4K

Sector Composition

Rank Sector Weight
1 Technology 33.09%
2 Healthcare 17.81%
3 Industrials 13.18%
4 Consumer Discretionary 10.44%
5 Financials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
51
JPMorgan Chase
JPM
$935B
$244K 0.16%
772
-25
-3% -$7.43K
AFL icon
52
Aflac
AFL
$64.9B
$201K 0.13%
+1,800
New +$189K
ADBE icon
53
Adobe
ADBE
$99.5B
-816
Closed -$316K
BALL icon
54
Ball Corp
BALL
$17.3B
-9,365
Closed -$525K
DE icon
55
Deere & Co
DE
$160B
-400
Closed -$203K

Similar funds

Elefante Mark B's Q3 2025 Portfolio in Review

As of Q3 2025, Elefante Mark B held 59 positions worth $156M, up 17% from $133M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Elefante Mark B deployed $16.3M of net new capital in Q3 2025, opening 2 new positions and adding to 40 existing holdings. Its largest new stake was ASML: 493 shares worth $479K.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Novo Nordisk, an estimated $97.5K trimmed.

  • Elefante Mark B's largest Q3 2025 buy was ASML: 493 shares worth $479K.
  • Elefante Mark B added most to Microsoft in Q3 2025, an estimated $923K increase.
  • Elefante Mark B's biggest Q3 2025 reduction was Novo Nordisk, cutting an estimated $97.5K.
  • Elefante Mark B fully exited Ball Corp in Q3 2025, selling an estimated $525K.
  • Elefante Mark B's ten largest holdings make up 45% of its $156M portfolio in Q3 2025.
  • Elefante Mark B opened 2 new positions and closed 3 in Q3 2025.
  • Elefante Mark B's portfolio value rose 17% quarter-over-quarter to $156M.

Based on Elefante Mark B's 13F filing for Q3 2025, filed 10 Nov 2025.